Trulieve’s DEA Strategy: Betting Big on Medical Reclassification Upside
By Sheeba M. | May 1, 2026 Trulieve’s DEA Strategy: Betting Big on Medical Reclassification Upside TL;DR: TRUL files DEA applications for medical marijuana registration across state-licensed operations—a sophisticated hedge on Schedule III tax relief worth ~$100M in net income upside if Section 280E relief passes. Trulieve Cannabis filed applications with the DEA for medical […]
Curaleaf Locks In European Footprint With Four 20 Pharma Acquisition
By Sheeba M. | May 1, 2026 Curaleaf Locks In European Footprint With Four 20 Pharma Acquisition TL;DR: CURLF completes Four 20 Pharma buyout, securing full control of licensed producer-distributor operations across Germany, UK, Poland, and Portugal—a strategic seed-to-patient supply chain bet ahead of potential global cannabis market expansion. Curaleaf Holdings completed its acquisition of […]
Cannabis Licensing Values Surge as Federal Clarity Approaches
By Sheeba M. | May 1, 2026 Cannabis Licensing Values Surge as Federal Clarity Approaches TL;DR: Premium state cannabis licenses are appreciating 3-5x faster than operator stock prices — forward-thinking investors should track license portfolios separately from operational performance. A surprising disconnect has emerged in cannabis valuations. While operator stock prices remain volatile, the underlying […]
Big Capital is Betting Big on Cannabis M&A Consolidation
By Sheeba M. | May 1, 2026 Big Capital is Betting Big on Cannabis M&A Consolidation TL;DR: Multi-state operators are consolidating assets in 2026 — those holding premium licenses and operational efficiency are acquisition targets driving Q2 valuations upward. The cannabis M&A landscape shifted dramatically in April. After months of consolidation uncertainty, institutional capital has […]
From the Village Green
Curated from social media posts and threads Trump Administration Reclassifies State Medical Cannabis as Less Dangerous Acting AG signs historic order moving state-licensed medical marijuana down from Schedule I, marking major policy shift after decades of federal prohibition. Read on AP News → Akanda (AKAN) Posts Stunning 1,700% April Rally on Rescheduling Optimism Small-cap medical […]
State Legalization Trends: Which Markets Are Attracting Capital in Q2 2026?
By Sheeba M. | May 01, 2026 State Legalization Trends Reshaping Capital Flows TL;DR: New Mexico and Maryland legalization campaigns gaining institutional attention; venture capital rotations suggest 2026 will see state-level wins outpace federal progress. The federal legalization clock keeps ticking, but savvy investors are increasingly betting on state-level opportunities. In Q2 2026, capital is […]
Cannabis ETF Flows Signal Investor Confidence in Market Recovery
By Sheeba M. | May 01, 2026 Cannabis ETF Flows Signal Market Recovery TL;DR: Major cannabis ETFs seeing sustained inflows as institutional investors re-enter the space post-rescheduling discussions, signaling confidence in 2026 valuations. The cannabis investment landscape shifted noticeably this week as two major ETFs tracking cannabis stocks posted their strongest weekly inflows in six […]
From the Village Green – May 1, 2026
Curated cannabis industry digest: Schedule III re-rating signals M&A acceleration. Trulieve, Curaleaf, Tilray make strategic moves. Edibles market projects $55B+ by mid-2030s.
Trulieve Stock Rally Stalls as Debt Concerns Resurface Ahead of Q1 Earnings
By Sheeba M. | April 30, 2026 Trulieve Stock Rally Stalls as Debt Concerns Resurface Ahead of Q1 Earnings TL;DR: Trulieve (TCNNF) shares slide 6% on debt refinancing concerns; earnings call May 15 could be make-or-break for stock momentum. Debt Load Looms Over Florida’s Cannabis Leader Trulieve Cannabis (TCNNF), the nation’s largest MSO by store […]
Cannabis ETF Outflows Accelerate as Investors Reassess MSO Growth Trajectory
By Sheeba M. | April 30, 2026 Cannabis ETF Outflows Accelerate as Investors Reassess MSO Growth Trajectory TL;DR: Major cannabis ETFs seeing $500M+ outflows as inflation pressures consumer spending; MSOs face margin compression despite revenue growth. Market Headwinds Impact Cannabis Funds Cannabis-focused ETFs including MSOS (AdvisorShares Pure US Cannabis) have experienced significant outflows over the […]